|
R&D Systems
recombinant mouse marco Recombinant Mouse Marco, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/recombinant+mouse+marco/Recombinant+Mouse+MARCO+Protein%2C+CF/pmc04563689-299-24-33 Average 92 stars, based on 1 article reviews
recombinant mouse marco - by Bioz Stars,
2026-09
92/100 stars
|
Buy from Supplier |
|
R&D Systems
recombinant mouse soluble marco smarco ![]() Recombinant Mouse Soluble Marco Smarco, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/recombinant+mouse+marco/Recombinant+Mouse+MARCO+Protein%2C+CF/pmc07682803-70-0-15 Average 91 stars, based on 1 article reviews
recombinant mouse soluble marco smarco - by Bioz Stars,
2026-09
91/100 stars
|
Buy from Supplier |
|
MARCO (macrophage receptor with collagenous structure) is an 80 kDa type II transmembrane glycoprotein that belongs to the class Ascavenger receptor family. Mouse MARCO consists of a 48 amino acid (aa) cytoplasmic domain, a 21
|
Buy from Supplier |
|
The Recombinant Mouse MARCO Protein from R D Systems is derived from NS0 The Recombinant Mouse MARCO Protein has been validated for the following applications Binding Activity
|
Buy from Supplier |
|
Recombinant Mouse Marco extracellular domain (NP_034896.1) (Gln 70-Ser 518), fused with a polyhistidine tag at the N-terminus, was produced in Human Cell.http://www.creativebiomart.net/description_7490_12.htm
|
Buy from Supplier |
Image Search Results
Journal: Journal of immunology (Baltimore, Md. : 1950)
Article Title: The class A scavenger receptor MARCO is the major phagocytic receptor for Clostridium sordellii expressed by human decidual macrophages
doi: 10.4049/jimmunol.1000989
Figure Lengend Snippet: A, Human DMs were pretreated with sMARCO (100 μg/ml) or the SR-AI/II-binding agent acetylated low density lipoprotein (AcLDL; 100 μg/ml) for 30 min and the phagocytosis of FITCC. sordellii was quantified by fluorometry after 180 min as detailed in Materials and Methods. B, Human DMs were pretreated with mouse anti-human monoclonal IgG directed against CD36 or CD163 (or an isotype control) at 50 μg/ml for 30 min and the phagocytosis of FITCC. sordellii was quantified by fluorometry after 180 min as detailed in Materials and Methods. Fucoidan pretreatment for 30 min at 500 μg/ml used as positive control for each. Data are representative from three independent experiments performed in octuplet with similar results. Results are expressed as a percentage of relative to untreated cells. **, P < 0.01 and ***, P < 0.001 vs. untreated cells.
Article Snippet:
Techniques: Binding Assay, Control, Positive Control